A Review on Pharmaceutical Marketing and Management

Abstract

Pharmaceutical marketing and management occupy a distinct position among commercial disciplines because they operate at the intersection of profit-driven business objectives and public health responsibility. This review examines the strategic, operational, and ethical dimensions of pharma marketing and management, drawing on recent literature covering promotional practices, digital transformation, supply chain operations, and regulatory oversight. The review finds that traditional promotional tools such as medical representative (MR) visits, free drug samples, and continuing medical education (CME) sponsorships remain influential in shaping physician prescribing behaviour, even as digital channels, artificial intelligence (AI), and data analytics increasingly reshape how companies engage healthcare professionals (HCPs) and patients. On the management side, the Indian pharmaceutical supply chain continues to face structural challenges including fragmentation, import dependence on active pharmaceutical ingredients (APIs), cold chain limitations, and counterfeit products, even as digital tools and regulatory reforms attempt to close these gaps. Ethical concerns persist around inducements, exaggerated promotional claims, and inconsistent enforcement of codes such as the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), which became legally binding in 2024. The review concludes that a balanced, ethically anchored, and technologically integrated approach to marketing and supply chain management is essential for the pharmaceutical sector to serve both commercial and public health goals sustainably.

Introduction

The text reviews pharmaceutical marketing and management, focusing on their importance in improving access to medicines, promoting pharmaceutical products ethically, and ensuring efficient supply chain operations, particularly in India.

Pharmaceutical marketing involves identifying healthcare needs, communicating scientific information about medicines, and promoting products to healthcare professionals and eligible consumers in accordance with regulations. Pharmaceutical management covers the operational activities required to manufacture, store, distribute, and deliver safe, effective, and quality-assured medicines to patients.

The main marketing strategies include market research, segmentation, targeting, positioning, and the marketing mix (4Ps): product, price, place, and promotion. Product managers oversee brand strategy, sales forecasting, promotional materials, and product performance, while sales-force managers supervise medical representatives, training, territory planning, and ethical promotional practices.

The text highlights that medical representative visits remain one of the most influential pharmaceutical promotional methods, followed by continuing medical education (CME) programs, health camps, and free medicine samples. However, the industry is increasingly adopting digital marketing, artificial intelligence, machine learning, predictive analytics, and personalized communication to improve customer engagement and marketing effectiveness. These developments also increase the need for transparent, evidence-based promotion and regulatory compliance.

Pharmaceutical distribution and supply chain management are equally important. The process involves manufacturers, carrying and forwarding agents, wholesalers, retailers, hospitals, and ultimately patients. Effective management requires accurate demand forecasting, inventory control, expiry-date monitoring, cold-chain maintenance, product traceability, and proper handling of returns and recalls.

In India, the pharmaceutical industry faces challenges such as fragmented distribution networks, infrastructure limitations, and dependence on imported raw materials. Regulatory measures, particularly the 2024 revision of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), strengthen expectations for ethical promotion and corporate accountability.

Conclusion

Pharmaceutical marketing and management sit at a genuinely unique crossroads of commerce and public health obligation. The evidence reviewed here shows that traditional relationship-based promotion, especially through medical representatives, continues to dominate prescribing influence even as digital and AI-driven marketing rapidly expands, particularly in patient engagement and data-driven targeting. On the operational side, India\'s pharmaceutical supply chain remains constrained by fragmentation, API import dependence, cold chain gaps, and counterfeit risk, though digital tools and stronger sourcing diversification are gradually addressing these weaknesses. Ethical and regulatory tightening, exemplified by the legally binding UCPMP 2024, signals a broader industry shift toward accountability, though enforcement consistency remains an open challenge. Future research and practice should prioritize the integration of ethical marketing conduct with resilient, technology-enabled supply chain management to ensure that pharmaceutical companies can meet both commercial objectives and their fundamental responsibility to patient welfare.

References

[1] EPRA International Journal of Multidisciplinary Research. (2025). A review on pharmaceutical marketing and business strategies. EPRA International Journal of Multidisciplinary Research. [2] RSIS International. (2025). A review on pharmaceutical marketing strategies from medical representatives\' perspective. International Journal of Research and Innovation in Social Science. [3] IJFMR. (2026). A review of pharmaceutical marketing and promotion technique. International Journal of Factual Research and Multidisciplinary Research, 8(1). [4] Epocrates. (2025). Navigating the pharma marketing landscape. [5] Tikamobile. (2025). Pharma marketing in 2025: Strategies for an intelligent, patient-centric, compliant future. [6] RSIS International Journal of Research and Innovation in Social Science. (2025). A review on pharmaceutical marketing strategies from medical representatives. International Journal of Research and Innovation in Social Science. [7] PNR Journal. (2024). Marketing strategies for pharmaceutical industry – A review. Journal of Pharmaceutical Negative Results, 15(S1). [8] Academia.edu. (2024). A systematic review of pharmaceutical marketing: 7Ps strategy and 6 key outcomes. [9] Healthgrades B2B. (2025). 2025 pharma marketing trends to watch. [10] PNR Journal. (2024). Marketing strategies for pharmaceutical industry – A review. Journal of Pharmaceutical Negative Results. [11] eMarketer. (2025). Top trends in pharma advertising for 2025. [12] World Journal of Pharmaceutical Research. (2024). [Special issue or article title]. World Journal of Pharmaceutical Research, 13(19). [13] IJPS Journal. (2025). A review on pharmaceutical sales and marketing. International Journal of Pharmaceutical Sciences. [14] 1Bavkar, S. (2025). [Article title missing]. International Journal of Pharmaceutical Sciences, 3(1), 2513–2526. [15] IJFMR. (2026). A review of pharmaceutical marketing and promotion techniques. International Journal of Factual Research and Multidisciplinary Research. [16] Maersk Insights. (2024). The rise and rise of the pharmaceutical supply chain in India. [17] Author, A. A. (2016). The Indian pharmaceutical industry\'s supply chain management strategies (Publication No. [Insert ID]) [Doctoral dissertation, Walden University]. Walden University ScholarWorks. [18] Scribd. (2026). Challenges in Indian pharma supply chain. [19] IJCRT. (2025). Supply chain management in the pharmaceutical industry: Operational challenges, technological integration, and strategies for performance. International Journal of Creative Research Thoughts. [20] Pharma Industrial India. (2025). Building a resilient pharma supply chain in India: Challenges, innovations and the road ahead. [21] Indian Pharmaceutical Alliance. (2025). Changing dynamics of Indian pharma supply chain. [22] JETIR. (2020). [Article title missing]. Journal of Emerging Technologies and Innovative Research, 7(10). [23] PNR Journal. (2024). Article download. Journal of Pharmaceutical Negative Results. [24] Kumar, B. (2017). Top challenges in pharmaceutical supply chain in India. LinkedIn Pulse. [25] Kuey Journal. (2023). A study on business ethics with special reference to Indian pharmaceutical marketing. Kuey Journal. [26] Sarade, R. (2025). India\'s pharma supply chain: Challenges and solutions. LinkedIn.

Copyright

Copyright © 2026 Omkar Narayan Musale, Dr. Nitin Gawai, Ms. Rekha Kolape. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.